Abby Shevitz

1.3k total citations
26 papers, 1.0k citations indexed

About

Abby Shevitz is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Abby Shevitz has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Emergency Medicine, 18 papers in Infectious Diseases and 12 papers in Virology. Recurrent topics in Abby Shevitz's work include HIV-related health complications and treatments (21 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (12 papers). Abby Shevitz is often cited by papers focused on HIV-related health complications and treatments (21 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (12 papers). Abby Shevitz collaborates with scholars based in United States and Canada. Abby Shevitz's co-authors include Tamsin A. Knox, Ronenn Roubenoff, Christine Wanke, Sherwood L. Gorbach, Julian Falutz, Jeffrey H. Samet, Ann Yelmokas McDermott, Donald P. Kotler, C. A. Wanke and Donna Spiegelman and has published in prestigious journals such as American Journal of Clinical Nutrition, Clinical Infectious Diseases and Journal of Applied Physiology.

In The Last Decade

Abby Shevitz

26 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abby Shevitz United States 18 636 597 420 181 82 26 1.0k
Mikaëla Smit United Kingdom 10 637 1.0× 685 1.1× 239 0.6× 276 1.5× 76 0.9× 20 1.0k
Renate Strehlau South Africa 21 800 1.3× 369 0.6× 515 1.2× 177 1.0× 37 0.5× 84 1.2k
Kathleen Melbourne United States 13 898 1.4× 1.1k 1.8× 543 1.3× 180 1.0× 53 0.6× 28 1.5k
S. Herrmann Australia 16 436 0.7× 427 0.7× 308 0.7× 259 1.4× 38 0.5× 40 997
S. M. Debanne United States 14 460 0.7× 286 0.5× 146 0.3× 369 2.0× 41 0.5× 18 1.0k
Kunjal Patel United States 17 469 0.7× 435 0.7× 190 0.5× 145 0.8× 18 0.2× 44 731
Chiara Stentarelli Italy 18 353 0.6× 577 1.0× 196 0.5× 358 2.0× 125 1.5× 34 977
Kris Ann Oursler United States 9 416 0.7× 291 0.5× 151 0.4× 302 1.7× 101 1.2× 14 752
Hector Bolívar United States 13 223 0.4× 306 0.5× 140 0.3× 110 0.6× 49 0.6× 34 542
Katherine W. Kooij Canada 12 234 0.4× 351 0.6× 122 0.3× 133 0.7× 70 0.9× 29 485

Countries citing papers authored by Abby Shevitz

Since Specialization
Citations

This map shows the geographic impact of Abby Shevitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Shevitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Shevitz more than expected).

Fields of papers citing papers by Abby Shevitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abby Shevitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Shevitz. The network helps show where Abby Shevitz may publish in the future.

Co-authorship network of co-authors of Abby Shevitz

This figure shows the co-authorship network connecting the top 25 collaborators of Abby Shevitz. A scholar is included among the top collaborators of Abby Shevitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abby Shevitz. Abby Shevitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tebas, Pablo, Richard Hafner, Karen T. Tashima, et al.. (2009). Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. Journal of Antimicrobial Chemotherapy. 63(5). 998–1005. 23 indexed citations
2.
Miller, Tracie L., E. John Orav, Steven E. Lipshultz, et al.. (2008). Risk Factors for Cardiovascular Disease in Children Infected with Human Immunodeficiency Virus-1. The Journal of Pediatrics. 153(4). 491–497. 39 indexed citations
3.
Tebas, Pablo, Jiameng Zhang, Kevin E. Yarasheski, et al.. (2007). Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 193–200. 46 indexed citations
4.
Kohli, Rakhi, Abby Shevitz, S. L. Gorbach, & C. A. Wanke. (2007). A randomized placebo‐controlled trial of metformin for the treatment of HIV lipodystrophy. HIV Medicine. 8(7). 420–426. 51 indexed citations
5.
Shepard, Donald S., et al.. (2007). Cost-effectiveness of clinical interventions for AIDS wasting. AIDS Care. 19(8). 996–1001. 7 indexed citations
6.
Shevitz, Abby, Ira B. Wilson, Ann Yelmokas McDermott, et al.. (2005). A Comparison of the Clinical and Cost-Effectiveness of 3 Intervention Strategies for AIDS Wasting. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 399–406. 24 indexed citations
7.
McDermott, Ann Yelmokas, Norma Terrin, C. A. Wanke, et al.. (2005). CD4+ Cell Count, Viral Load, and Highly Active Antiretroviral Therapy Use Are Independent Predictors of Body Composition Alterations in HIV-Infected Adults: A Longitudinal Study. Clinical Infectious Diseases. 41(11). 1662–1670. 45 indexed citations
8.
Goldin, Barry R., Wenjun Li, Keith G. Mansfield, et al.. (2005). The Effect of Micronutrient Supplementation on Disease Progression and Death in Simian Immunodeficiency Virus–Infected Juvenile Male Rhesus Macaques. The Journal of Infectious Diseases. 192(2). 311–318. 4 indexed citations
9.
Jones, Clara Y., Ira B. Wilson, Andrew S. Greenberg, et al.. (2005). Insulin Resistance in HIV-Infected Men and Women in the Nutrition for Healthy Living Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(2). 202–211. 26 indexed citations
10.
Hellinger, James, et al.. (2005). Pilot Study of Saquinavir and Lopinavir/Ritonavir Twice Daily in Protease Inhibitor-Naive HIV-Positive Patients. HIV Clinical Trials. 6(2). 107–117. 10 indexed citations
11.
McDermott, Ann Yelmokas, Abby Shevitz, Aviva Must, et al.. (2003). Nutrition Treatment for HIV Wasting: A Prescription for Food as Medicine. Nutrition in Clinical Practice. 18(1). 86–94. 17 indexed citations
12.
Wanke, Christine, Julian Falutz, Abby Shevitz, John Phair, & Donald P. Kotler. (2002). Clinical Evaluation and Management of Metabolic and Morphologic Abnormalities Associated with Human Immunodeficiency Virus. Clinical Infectious Diseases. 34(2). 248–259. 44 indexed citations
13.
McDermott, Ann Yelmokas, Abby Shevitz, Tamsin A. Knox, et al.. (2001). Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. American Journal of Clinical Nutrition. 74(5). 679–686. 81 indexed citations
14.
Shevitz, Abby & Tamsin A. Knox. (2001). Nutrition in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 32(12). 1769–1775. 38 indexed citations
15.
Shevitz, Abby, et al.. (1999). Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS. 13(11). 1351–1357. 86 indexed citations
16.
Shevitz, Abby, Michele Pagano, Mary Ann Chiasson, Nancy Müeller, & P. Thomas. (1996). The Association Between Youth, Women, and Acquired Immunodeficiency Syndrome. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(5). 427–433. 7 indexed citations
17.
Cohen, Cyrille J., James Hellinger, John Day, et al.. (1996). Lack of Effect of Cimetidine on Lymphocyte Subsets in Patients Infected with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 23(5). 1049–1054. 1 indexed citations
18.
McIntosh, Kenneth, Abby Shevitz, Daniela Zaknun, et al.. (1996). Age- and Time-related Changes in Extracellular Viral Load in Children Vertically Infected by Human Immunodeficiency Virus. The Pediatric Infectious Disease Journal. 15(12). 1087–1091. 84 indexed citations
19.
Samet, Jeffrey H., Howard Libman, Kathleen A. Steger, et al.. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. The American Journal of Medicine. 92(5). 495–502. 191 indexed citations
20.
Samet, Jeffrey H., et al.. (1990). Hospitalization decision in febrile intravenous drug users. The American Journal of Medicine. 89(1). 53–57. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikaëla Smit Breakdown of academic impact, for papers by Renate Strehlau Breakdown of academic impact, for papers by Kathleen Melbourne Breakdown of academic impact, for papers by S. Herrmann Breakdown of academic impact, for papers by S. M. Debanne Breakdown of academic impact, for papers by Kunjal Patel Breakdown of academic impact, for papers by Chiara Stentarelli Breakdown of academic impact, for papers by Kris Ann Oursler Breakdown of academic impact, for papers by Hector Bolívar Breakdown of academic impact, for papers by Katherine W. Kooij
Rankless by CCL
2026